Latin America Advanced Wound Care Companies

The LATAM advanced wound care market is expected to grow from USD 312.8 million in 2025 to reach USD 498.2 million by 2030, at a CAGR of 9.8% during the forecast period.

LATAM advanced wound care products are essential for the treatment of acute & chronic wounds as they promote natural healing and prevent infection. These comprise foam dressings and hydrocolloid dressings, among others, that aim to protect wounds from external contaminants, thus promoting natural healing. LATAM advanced wound care products ensure cost & accessibility and are widely used across hospitals, clinics, and home healthcare in Latin America. By adhering to industry standards for regulatory compliance, these products aid in appropriately managing wounds, reducing complications, and improving patient outcomes.

To know about the assumptions considered for the study download the pdf brochure

The notable companies in this market include Solventum (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Mölnlycke AB (Sweden), Essity Aktiebolag (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Coloplast Group (Denmark), Integra LifeSciences Corporation (US), MATIV HOLDINGS, INC. (US), Owens &  Minor (US), and AVERY DENNISON CORPORATION (US), among others.

Market Ranking:

Companies in the LATAM advanced wound care market are ranked according to their performance. It considers factors such as sales from wound care, recent product launches, and new product approvals. To ensure accuracy, the information gathered is through research & verified opinion from industry experts. Based on this analysis, the top three players in the market are Solventum (US), Molnlycke AB (Sweden), and Coloplast Group (Denmark). These companies dominate the LATAM advanced wound care market owing to their strong market presence, extensive product portfolios, and extensive innovation.

Solventum (US)

In April 2024, after its spin-off from 3M, Solventum began its operations as a standalone company. Although the firm profited from 3M's assets and reputation previously, it is now focused on creating its own brand identity. Solventum creates, produces, and markets various products to satisfy customer demands and establish a brand image. The company primarily operates through four business segments: MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration. Solventum’s integration of material science and digital capabilities is expected to strengthen its competitive edge, improving its clinical & economic outcomes for healthcare providers.

Mölnlycke AB (Sweden)

Mölnlycke AB has a global presence owing to its vast distribution network. The firm has a presence across LATAM, including Argentina, Colombia, Brazil, and Mexico. The company expands its presence via inorganic strategies to enhance business operations. For instance, in October 2024, Mölnlycke acquired P.G.F. Industry Solutions (Austria), the manufacturer of Granudacyn wound cleansing & moistening solutions. The acquisition strengthens Mölnlycke’s wound care portfolio and expands the distribution of Granudacyn, which is currently available in over 50 countries. Similarly, in October 2024,  the company partnered with Transdiagen (UK) to explore novel wound gene signatures for wound care product innovation. The collaboration provides Mölnlycke access to Transdiagen’s models to generate insights into biological wound treatment solutions and enhance evidence-based product development.

Coloplast Group (Denmark)

Coloplast is a leading provider of LATAM advanced wound care products. The firm offers various medical products to support patient care and improve treatment outcomes. With a robust product portfolio, Coloplast is one of the leading players in the LATAM advanced wound care market. The company operates through five segments: Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology, and Voice & Respiratory Care. The company provides wound care products through its Advanced Wound Care segment. The Wound & Skin Care subsegment offers hydrocolloid dressings under the Comfeel brand while foam dressings under the Biatain brand. Coloplast’s products are provided in hospitals and through wholesalers and retailers.

Related Reports:

Latin America Advanced Wound Care Market by Product (Foam, Hydrocolloid, Film, Alginate, Collagen), Wound Type (Chronic (Diabetic Foot Ulcers, Pressure Ulcers), Acute (Surgical, Burns)), End User (Hospitals, Clinics, ASCs), Region - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com